EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPEMG00000018091
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPEMG00000016961
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSPEMG00000018432
Gene Symbol: PDPK1
1 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSPEMG00000014349
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSPEMG00000008549
Gene Symbol: LOC102907678
3 Cross references
152 Possible Orthologues:

40s Ribosomal Protein S27-Like

Ensembl ID : ENSPEMG00000030510
Gene Symbol: LOC102926625
2 Cross references
106 Possible Orthologues:

40s Ribosomal Protein S4, X Isoform-Like

Ensembl ID : ENSPEMG00000012614
Gene Symbol: LOC102925380
2 Cross references
181 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSPEMG00000001273
Gene Symbol: NT5E
3 Cross references
247 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2a

Ensembl ID : ENSPEMG00000019339
Gene Symbol: HTR2A
1 Cross references
218 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b

Ensembl ID : ENSPEMG00000023694
Gene Symbol: HTR2B
1 Cross references
204 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 3a

Ensembl ID : ENSPEMG00000011767
Gene Symbol: HTR3A
1 Cross references
205 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSPEMG00000001034
Gene Symbol: HTR1A
3 Cross references
147 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).